We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.15B
AUM Growth
+$53.8M
Cap. Flow
-$307K
Cap. Flow %
-0.03%
Top 10 Hldgs %
43.07%
Holding
216
New
5
Increased
77
Reduced
71
Closed
20

Top Buys

Rank Stock Value
1
JD icon
JD.com
JD
+$5.31M
2
PEP icon
PepsiCo
PEP
+$5.19M
3
AAPL icon
Apple
AAPL
+$4.75M
4
CL icon
Colgate-Palmolive
CL
+$4.3M
5
PLD icon
Prologis
PLD
+$3.8M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$6.51M
2
IBM icon
IBM
IBM
+$5.63M
3
CVX icon
Chevron
CVX
+$4.3M
4
NKE icon
Nike
NKE
+$3.97M
5
KMI icon
Kinder Morgan
KMI
+$3.95M

Sector Composition

Rank Sector Weight
1 Consumer Staples 29.57%
2 Healthcare 17.59%
3 Financials 11%
4 Technology 9.5%
5 Industrials 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
1
Walmart Inc
WMT
$893B
$207M 18.02%
10,131,819
+68,106
+0.7% +$1.37M
BMY icon
2
Bristol-Myers Squibb
BMY
$123B
$68.8M 5.99%
1,000,296
+5,840
+0.6% +$386K
KO icon
3
Coca-Cola
KO
$353B
$55.1M 4.79%
1,281,798
-6,647
-0.5% -$282K
XOM icon
4
ExxonMobil
XOM
$615B
$40.8M 3.55%
523,722
-7,679
-1% -$614K
PG icon
5
Procter & Gamble
PG
$347B
$27.9M 2.43%
350,852
-49,617
-12% -$3.79M
UPS icon
6
United Parcel Service
UPS
$96.2B
$23M 2%
239,002
+24,960
+12% +$2.55M
AFL icon
7
Aflac
AFL
$63.2B
$20.1M 1.75%
670,446
+24,500
+4% +$763K
MSFT icon
8
Microsoft
MSFT
$2.99T
$17.5M 1.52%
315,626
+36,765
+13% +$1.93M
AAPL icon
9
Apple
AAPL
$4.8T
$17.3M 1.51%
657,600
+166,052
+34% +$4.75M
META icon
10
Meta Platforms (Facebook)
META
$1.64T
$17.2M 1.5%
164,800
+13,000
+9% +$1.34M
JNJ icon
11
Johnson & Johnson
JNJ
$599B
$16M 1.39%
155,978
-4,056
-3% -$408K
GE icon
12
GE Aerospace
GE
$354B
$14.6M 1.27%
97,699
-1,845
-2% -$262K
PAYX icon
13
Paychex
PAYX
$41B
$14M 1.22%
264,512
+2,352
+0.9% +$123K
ABT icon
14
Abbott
ABT
$177B
$13.6M 1.18%
302,950
+14,000
+5% +$618K
CL icon
15
Colgate-Palmolive
CL
$73.6B
$13.6M 1.18%
203,639
+64,594
+46% +$4.3M
PEP icon
16
PepsiCo
PEP
$185B
$13.6M 1.18%
135,733
+52,002
+62% +$5.19M
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$122B
$12.7M 1.1%
100,687
MRK icon
18
Merck
MRK
$307B
$12.2M 1.06%
242,621
-3,019
-1% -$152K
SBUX icon
19
Starbucks
SBUX
$119B
$11.3M 0.98%
187,885
+23,390
+14% +$1.42M
PFE icon
20
Pfizer
PFE
$141B
$10.5M 0.92%
344,366
+329
+0.1% +$10.3K
USB icon
21
US Bancorp
USB
$98.4B
$10.4M 0.9%
243,417
+38,950
+19% +$1.66M
JPM icon
22
JPMorgan Chase
JPM
$901B
$10.2M 0.89%
155,211
+8,423
+6% +$548K
WFC icon
23
Wells Fargo
WFC
$261B
$9.9M 0.86%
182,205
+10,173
+6% +$552K
LOW icon
24
Lowe's Companies
LOW
$115B
$9.79M 0.85%
128,798
+22,354
+21% +$1.66M
INTC icon
25
Intel
INTC
$488B
$9.73M 0.85%
282,406
+75,300
+36% +$2.55M

Similar funds

Cullinan Associates's Q4 2015 Portfolio in Review

As of Q4 2015, Cullinan Associates held 216 positions worth $1.15B, up 4.9% from $1.09B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Cullinan Associates's Q4 2015 filing shows 5 new, 77 increased, 71 reduced and 20 closed positions. Its largest new stake was JD.com: 180,000 shares worth $5.81M. The largest sale was Qualcomm, an estimated $6.51M.

By sector, the portfolio is most concentrated in Consumer Staples at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.

  • Cullinan Associates's largest Q4 2015 buy was JD.com: 180,000 shares worth $5.81M.
  • Cullinan Associates added most to PepsiCo in Q4 2015, an estimated $5.19M increase.
  • Cullinan Associates's biggest Q4 2015 reduction was Qualcomm, cutting an estimated $6.51M.
  • Cullinan Associates fully exited Kinder Morgan in Q4 2015, selling an estimated $3.95M.
  • Cullinan Associates's ten largest holdings make up 43% of its $1.15B portfolio in Q4 2015.
  • Cullinan Associates opened 5 new positions and closed 20 in Q4 2015.
  • Cullinan Associates's portfolio value rose 4.9% quarter-over-quarter to $1.15B.

Based on Cullinan Associates's 13F filing for Q4 2015, filed 12 Jan 2016.